Chief Executive Officer
Josh has held senior management positions overseeing multiple aspects of technology, with a specialization in artificial intelligence, data strategy, digital transformation, and business transformation. Previously, he held senior roles at Publicis Sapient, including Global Head of Data and AI at Sapient Global Markets, where he led risk strategy initiatives. With an undergraduate education from MIT, Josh has a strong focus on leveraging AI for deep data problems in healthcare, medical research and genomics.
Chief Revenue Officer
Sean is a former President and Head of Investment Banking at CG Capital Markets, Managing Director at UBS Investment Bank, and Managing Director of Capital Markets at Coventry Capital. His expertise spans a broad spectrum of markets and industries, with a broad focus on technology. Sean’s career includes leadership positions at Bank of America, BNP Paribas, and JP Morgan.
Head of Data Partnerships
Kamil directs partnerships, and leads piloting and execution of large-scale population genomics programs throughout the world. He is a software engineer by training, yet also has extensive experience in guiding and managing successful execution of complex programs across several industries, with a key focus on genomics and medical research projects and partnerships. He is a co-founder of Syndesis, the largest repository of de-identified RWD (real world data) from the southern hemisphere.
Head of Governance
Admiral Sir George Zambellas is the former First Sea Lord and Chief of the UK Royal Navy. He has extensive leadership experience in the military and technology sectors. During his three-year tenure as First Sea Lord, he successfully reset the Royal Navy’s global strategy and priorities, with a particular focus on advanced technology and artificial intelligence. An engineer by training, Sir George’s love of emerging technologies has led him to become a leading figure in AI, robotics, encryption and data security.
Precision Medicine Lead
George is directing the development of the Xeomics Precision Medicine Reporting Suite. He has a PhD in Artificial Intelligence in Medicine, and has extensive experience in software product development in healthcare, as well as in data and analytics. He has worked at the European Bioinformatics Institute in Cambridge UK where the produced the business case for Elixir, Europe’s next generation bioinformatics infrastructure.
Life Sciences Lead
James was a Managing Director at Genomics England, one of the world’s largest and most successful population genomic sequencing programs. He developed and led the Cancer Research UK, AstraZeneca, and Pfizer’s Stratified Medicine Program. He has advised national and regional sequencing programs, including France Génomique and Genome Canada. He was a member of the UK Human Genomic Strategy Group and Illumina’s Global Population Sequencing Leadership Council.
Data Science Lead
Dave has worked in the healthcare industry for over 20 years, helping to complex transform data into useful real-world insights. He has worked with major UK datasets such as Hospital Episode Statistics (HES), Clinical Practice Research Datalink (CPRD), and Optimum Patient Care Research Database (OPCRD). Dave has been keenly focused on applying machine learning to combined phenotype and genotype data in order to provide predictive insights into identifying patients globally with previously undiagnosed rare diseases.
Chief Technology Officer
Guru is a deeply experienced leader specializing in data, technology, and digital transformation. His career includes leadership roles at Syndesis Health, Sapient, Goldman Sachs, and Deutsche Bank, with expertise in data platforms, cybersecurity, and cloud computing. He holds advanced degrees in Electrical Engineering and Computer Science.
Chief Experience Officer
Howard has over 20 years experience leading projects in UX strategy, design and data visualization for Merck, Pfizer, the Federal Reserve, Goldman Sachs, the Museum of Modern Art, and many others. He was North American lead for data visualization at Sapient, and founder of Heliotrope and Tacitus, two companies focused on data viz for genomics and economics. He served on three panels for the National Institutes of Health focused on analytics tools for cancer research, and pioneered the use of game platforms and 3D immersive environments for genomic research.
Chief Operating Officer
A graduate of MIT, Hans was previously COO of Agorai, which helps companies drive value from data assets (and AI applications that leverage them) in ways that deliver meaningful commercial returns for global companies in many industries. Hans was also Group Vice President for Publicis Sapient (a division of the global Publicis Groupe). In over 20 years with PS, Hans served a broad spectrum of global clients before running the Groupe’s flagship AI program, as well as implementing the Publicis Global Delivery (PGD) model across the Americas.
Chief Financial Officer
Toby has over 25 years of experience in investment banking and infrastructure, specializing in operations technology. He has held senior management roles at major financial institutions, including JP Morgan and TD Securities, managing large teams and overseeing equity derivatives, financial risk measurement, and middle office functions across multiple global locations. His expertise includes private equity and commodities trading.